tiprankstipranks
Physiomics Announces Board Reshuffle and IP Deal
Company Announcements

Physiomics Announces Board Reshuffle and IP Deal

Physiomics (GB:PYC) has released an update.

Don't Miss Our Christmas Offers:

Physiomics PLC, a key player in mathematical modelling for therapeutic development, has announced that Dr Christophe Chassagnole will resign as Director and Chief Scientific Officer on May 31, 2024, to explore new career opportunities. He leaves behind a legacy of contributions to the company’s services and intellectual property, with a consulting agreement in place to ensure his expertise remains accessible to Physiomics. The company has also entered into an IP Licensing Agreement with Dr Chassagnole, providing it with a royalty on sales derived from licensed software and models.

For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskPhysiomics Strengthens Collaboration with Numab Therapeutics
TipRanks UK Auto-Generated NewsdeskPhysiomics Lands Major Contract in Cancer Drug Development
TipRanks UK Auto-Generated NewsdeskPhysiomics Gains Strong Shareholder Support at AGM
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App